Panel Discussion | Mechanical Circulatory Support for High-Risk PCI and Shock

Tuesday, March 10, 2026

8:30 AM - 9:00 AM EST

Location: International Ballroom East

Moderator(s)

Mitchell Krucoff, MD, FACC, FAHA, FSCAI

Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States

Disclosure information not submitted.
Robert W. Yeh, MD, MSc

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

David Israeli, MD, MBA

CEO
Magenta Medical Ltd.
New York, New York, United States

Disclosure(s): Magenta Medical Ltd.: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)
Michael C. John, MPH

Chief Regulatory and Innovation Officer
CBSET
Lexington, Massachusetts, United States

Disclosure(s): No financial relationships to disclose
Mauro Moscucci, MD, MBA, MPH

Medical Officer
Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

Disclosure(s): No financial relationships to disclose
Jeffrey J. Popma, MD

Chief Scientific Officer
CRF
Newton, Massachusetts, United States

Disclosure(s): Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)
Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Advisor
Abiomed a Johnson + Johnson MedTech Company
Charlotte, North Carolina, United States

Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)

Disclosure(s):

Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

Suzanne J. Baron, MD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Acarix: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corp: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chiesi: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

David Israeli, MD, MBA: Magenta Medical Ltd.: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)

Michael C. John, MPH: No financial relationships to disclose

Jeffrey J. Popma, MD: Medtronic: CMO ended Nov 2024 (Terminated, November 1, 2024), Stock-publicly held company (excluding mutual/index funds) (Terminated, November 1, 2024)

Charles A. Simonton, MD, FACC, FSCAI: Abiomed / Johnson & Johnson: Employee (Ongoing)